In a stunning move, Health Secretary Robert F. Kennedy Jr. has axed 22 federal contracts worth nearly $500 million for mRNA vaccine development, calling the technology ineffective against respiratory infections like COVID and flu. The decision, affecting giants like Pfizer and Moderna, marks a sharp turn in U.S. vaccine strategy.
















